Metraipolis › archive › dc_c319f71b1fa3

Developing In Vitro-In Vivo Correlation for Bicalutamide Immediate-Release Dosage Forms with the Biphasic In Vitro Dissolution Test — Europe PMC PMID:41012463

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41012463
DOI
10.3390/pharmaceutics17091126
License (as archived)
solo-consultazione
Archived
2026-11-10T07:35:55.561Z
SHA-256 of the archived text
28fe56faf36055e299b10ce1f9db0cb0da5eae5593921c6ba78e5691bba03cb1
Stable URL of this page
https://metraipolis.com/documento/dc_c319f71b1fa3

How to cite

Developing In Vitro-In Vivo Correlation for Bicalutamide Immediate-Release Dosage Forms with the Biphasic In Vitro Dissolution Test — Europe PMC PMID:41012463 — Europe PMC (en), https://europepmc.org/article/MED/41012463 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c319f71b1fa3 (Metraipolis archive dc_c319f71b1fa3, sha256 28fe56faf36055e299b10ce1f9db0cb0da5eae5593921c6ba78e5691bba03cb1)
BibTeX
@misc{dcc319f71b1fa3,
  title = {Developing In Vitro-In Vivo Correlation for Bicalutamide Immediate-Release Dosage Forms with the Biphasic In Vitro Dissolution Test — Europe PMC PMID:41012463},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41012463},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c319f71b1fa3; sha256 28fe56faf36055e299b10ce1f9db0cb0da5eae5593921c6ba78e5691bba03cb1},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41012463. Agents can read the archived copy with the MCP tool read_document.